Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
123,650,000
-
Total 13F shares
-
121,956,653
-
Share change
-
+6,878,167
-
Total reported value
-
$1,561,931,486
-
Put/Call ratio
-
12%
-
Price per share
-
$12.82
-
Number of holders
-
164
-
Value change
-
+$88,012,978
-
Number of buys
-
99
-
Number of sells
-
54
Institutional Holders of HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) as of Q2 2017
As of 30 Jun 2017,
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
121,956,653 shares.
The largest 10 holders included
Third Security, LLC, BlackRock Inc., IRIDIAN ASSET MANAGEMENT LLC/CT, VANGUARD GROUP INC, BB BIOTECH AG, First Eagle Investment Management, LLC, FMR LLC, Invesco Ltd., SENZAR ASSET MANAGEMENT, LLC, and STATE STREET CORP.
This page lists
164
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.